Finding a drug used in the treatment of other viral diseases that acts against coronavirus 2 (SARS-CoV-2) is the purpose of the COVID-PHYM citizen science project, promoted by the Higher Council for Scientific Research (CSIC) and the Foundation Ibercivis. Since some drugs in use have already been shown to be safe enough for human health, they may be available to treat patients with COVID-19 much sooner than a newly created compound and thus accelerate control of the pandemic.

Under this premise, the Biophym Group of the Institute of Matter Structure of the CSIC has proposed to perform simulations of the interaction of drugs used against Ebola, HIV infection, influenza or hepatitis B with the replication machinery of the genome of the SARS-Co-V virus. To do so, it will resort to computer techniques and the help of the computers of thousands of volunteers connected through Ibercivis' distributed computing platform. These operations will show if any of the molecules manages to inhibit a key protein in the multiplication of the virus called 'RNA-dependent RNA polymerase'. If so, the drug would become an ideal candidate for testing in human clinical trials.

https://boinc.ibercivis.es/

meanwhile ibercivis is added to boinc stats i am contributing to it ... .

Hope it will be solved soon !!